Rocket Lab shares declined 2.93% to $68.15 on February 24, 2026, as investors shifted focus toward SpaceX IPO speculation and news of Congress withholding NASA funding for the 2031 Mars mission.
- The company reports Q4 2025 earnings on February 26 with a Buy consensus, an estimated $178M in revenue, and an expected 9-cent EPS loss.
- Bank of America has issued price targets up to $120, bolstered by the upcoming Cassowary Vex defense mission scheduled for late February.
- While the stock has achieved 206% gains over the last 12 months, technical indicators remain mixed following the recent price dip.